IRWD PEER ANALYSIS

Ironwood Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

IRWDIronwood Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

IRWDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	IRWD	GENIL	ECILC	HLN	BHC	TLRY	Ind. Median
P/E	7.06●	46.82	—	31.28	—	—	21.37
P/B	-3.32●	3.47	0.80	1.98	-0.88	0.33	1.82
EV/EBITDA	5.30	14.07	33.84	19.15	4.05●	—	12.26
P/S	2.00	1.86	5.03	3.94	0.21●	0.60	2.09

Financial Health
Metric	IRWD	GENIL	ECILC	HLN	BHC	TLRY	Ind. Median
Current Ratio	1.41	1.33	1.73	0.92	1.32	2.79●	2.22
Debt/Equity	-275.1%	41.0%	5.9%	52.3%	-1,010.0%●	20.4%	46.3%
NetDebt/EBITDA	1.82	1.10	-0.10●	3.50	3.71	-0.07	1.24

Profitability
Metric	IRWD	GENIL	ECILC	HLN	BHC	TLRY	Ind. Median
Net Margin	28.3%●	4.0%	-3.6%	12.6%	-13.5%	-158.8%	4.0%
ROE	—	8.7%●	-0.6%	6.3%	—	-63.6%	6.4%
ROA	26.8%●	4.8%	-0.5%	3.2%	-4.7%	-49.7%	3.4%
EBITDA Margin	57.3%	14.3%	14.8%	25.2%	60.0%●	-156.2%	18.2%

Growth + Dividend
Metric	IRWD	GENIL	ECILC	HLN	BHC	TLRY	Ind. Median
Rev. Growth	13.8%	16.3%●	-2.3%	-26.7%	-9.9%	3.8%	7.5%
NI Growth	—	146.6%●	—	-14.2%	—	—	5.0%
Div. Yield	—	0.0%	2.6%●	2.0%	0.0%	—	2.0%
Payout	—	0.0%	-365.1%	40.0%	0.0%	—	0.8%

Valuation
Metric	IRWD	AMPH	PCRX	EBS	EOLS	PAHC	Ind. Median
P/E	7.06●	11.52	202.16	—	—	14.33	21.37
P/B	-3.32	1.18	1.59	0.89	-15.63●	3.77	1.82
EV/EBITDA	5.30●	6.81	10.54	5.70	—	9.21	12.26
P/S	2.00	1.27	1.41	0.69●	1.49	0.91	2.09

Financial Health
Metric	IRWD	AMPH	PCRX	EBS	EOLS	PAHC	Ind. Median
Current Ratio	1.41	3.85	4.73●	4.29	2.04	3.17	2.22
Debt/Equity	-275.1%	88.7%	62.9%	109.7%	-573.0%●	217.6%	46.3%
NetDebt/EBITDA	1.82	2.05	1.77	2.68	-8.20●	3.15	1.24

Profitability
Metric	IRWD	AMPH	PCRX	EBS	EOLS	PAHC	Ind. Median
Net Margin	28.3%●	11.0%	0.7%	-1.3%	-14.4%	6.3%	4.0%
ROE	—	10.4%	0.7%	-1.6%	—	30.3%●	6.4%
ROA	26.8%●	4.8%	0.4%	-0.6%	-20.0%	6.9%	3.4%
EBITDA Margin	57.3%●	26.6%	16.1%	22.8%	-4.6%	15.0%	18.2%

Growth + Dividend
Metric	IRWD	AMPH	PCRX	EBS	EOLS	PAHC	Ind. Median
Rev. Growth	13.8%	-1.1%	4.6%	-29.9%	9.6%	26.0%●	7.5%
NI Growth	—	-44.1%	—	—	—	199.6%●	5.0%
Div. Yield	—	—	—	—	—	1.5%	2.0%
Payout	—	—	—	—	—	20.4%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on IRWD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.